| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 09/27/2000 | EP1038880A2 Androstanes and pregnanes for allosteric modulation of GABA receptor |
| 09/14/2000 | WO2000053620A1 Novel estradiol derivatives |
| 09/14/2000 | WO2000053618A1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis |
| 09/06/2000 | EP1032584A1 Novel 19-nor steroids substituted in position 11beta, preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 09/06/2000 | CN1056151C 17-deoxycorticosteroid-21-(O)-carboxylic esters, process for their preparation and pharmaceuticals containing these compounds |
| 08/23/2000 | EP0752860B1 Androstanes and pregnanes for allosteric modulation of gaba receptor |
| 08/17/2000 | WO2000047603A2 16-hydroxyestratrienes as selective estrogens |
| 08/17/2000 | CA2359660A1 16-hydroxyestratrienes as selective estrogens |
| 08/16/2000 | EP0755922B1 22-thiavitamin d3 derivative |
| 08/10/2000 | DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective |
| 08/09/2000 | EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 07/26/2000 | CN1054856C New 19-nor steroids having phenoxyalkylsulphonemide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical |
| 07/19/2000 | EP0641355B1 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/19/2000 | CN1260802A 20-aralkyl-5 'alpha'-pregnane derivatives |
| 07/18/2000 | US6090957 Process for preparing neuromuscular blocking agents and intermediates useful therefor |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/06/2000 | WO2000039148A1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 07/05/2000 | EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
| 07/05/2000 | CN1054133C 17-spiromethylene steroids |
| 07/04/2000 | US6083941 Inhibition of NMDA receptor activity by pregnenolone sulfate derivatives |
| 06/29/2000 | DE19860719A1 Neue Testosteronderivate und ihre Verwendung zur Langzeittherapie von Androgen-abhängigen Erkrankungen New testosterone derivatives and their use for long-term therapy of androgen-dependent diseases |
| 06/27/2000 | US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
| 06/06/2000 | US6072068 Treating glucocorticoid-dependent diseases or symptoms |
| 05/31/2000 | CN1255142A B-ring estratriene diol sulphates |
| 05/31/2000 | CN1255141A Salts of 5 'alpha'-pregn-16-en-3 'beta'-ol-20-one 3-sulphate ester with progestin activity |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/24/2000 | CN1254343A Pregnane 3,20 diol mono- and di-sulphates |
| 05/24/2000 | CN1254342A Pharmaceutically acceptable salts of 5 alpha-pregnan-3-beta, 16 alpha-diol-20-one 3-sulfate useful as progestins and CNS disorders |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/17/2000 | CN1253564A Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 05/10/2000 | EP0998484A1 Tharapeutically active compounds with low systemic activity due to reduced half-life |
| 05/10/2000 | CN1052237C Steroids with 17-spiromethylene lactone or ortho -hydroxyl inner ether base |
| 04/12/2000 | CN1051316C Cortinoid derivative, its producing process and medicine containing the same |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/29/2000 | EP0602123B1 Steroid sulphatase inhibitors |
| 03/22/2000 | EP0986573A1 Non-estrogenic estradiol derivatives with an antioxidant effect |
| 03/22/2000 | CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 03/15/2000 | EP0984980A1 20-ARALKYL-5$g(a)-PREGNANE DERIVATIVES |
| 03/15/2000 | EP0533703B1 Use of steroids for the inhibition of angiogenesis |
| 03/08/2000 | EP0983294A1 B-ring estratriene diol sulphates |
| 03/08/2000 | EP0783513A4 Novel estrenes for inducing hypothalamic effects |
| 03/01/2000 | EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production |
| 03/01/2000 | EP0981538A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders |
| 02/23/2000 | EP0980384A1 Pregnane 3,2o diol mono- and di-sulphates |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980381A1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| 02/23/2000 | EP0898579B1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds |
| 01/26/2000 | EP0973792A1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives |
| 01/26/2000 | EP0973791A2 Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds |
| 01/26/2000 | EP0973790A1 Estra-5(10),7-dienes with estrogenic activity |
| 01/25/2000 | US6017904 Steroid sulphatase inhibitors |
| 01/11/2000 | US6013244 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
| 12/29/1999 | CN1239967A 8(9)-dehydroestradiol derivatives |
| 11/30/1999 | US5994568 Estrenes for inducing hypothalamic effects |
| 11/24/1999 | EP0633893B1 17-substituted steroids useful in cancer treatment |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 11/17/1999 | CN1046502C 22-thiavitamin D3 derivative |
| 11/09/1999 | US5981744 Removing an 11-alpha leaving group from starting compound to generate a double bond between the 9- and 11-carbon atoms |
| 11/09/1999 | US5981517 Androstene derivatives |
| 11/02/1999 | US5977096 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 10/26/1999 | US5972922 Steroids which inhibit angiogenesis |
| 10/19/1999 | US5969168 Stimulate autonomic activity |
| 10/12/1999 | US5965552 Administering androsta-4,16-dien-3-ol for treating tension, reducing anxiety; administering to the vomeronasal organ of individual |
| 10/06/1999 | EP0947504A1 16-ene-vitamin d derivatives |
| 10/06/1999 | EP0946583A1 Bissteroidal compounds and their use for the preparation of chiral complexes |
| 09/29/1999 | EP0944644A2 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/22/1999 | EP0942918A2 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin d analogs, and other compounds |
| 09/21/1999 | US5955584 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 09/15/1999 | EP0941054A1 Use of sterolsulfates as active substances for producing means to inhibit serin proteases |
| 09/14/1999 | CA2170869C Amine-derivatized nucleosides and oligonucleosides |
| 08/25/1999 | EP0937100A1 A novel polymorphic crystalline form of fluticasone propionate, a method for its production and pharmaceutical compositions thereof |
| 08/17/1999 | US5939570 Estrenes for inducing hypothalamic effects |
| 08/17/1999 | US5939545 Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| 08/12/1999 | DE19806357A1 New 11 beta-halo-7 alpha-substituted estratrienes useful for treating e.g. estrogen-dependent disease such as breast cancer |
| 08/11/1999 | EP0934334A1 8(9)-dehydroestradiol derivatives |
| 08/11/1999 | EP0649431B1 17-amino substituted 4-azasteroid 5-alpha-reductase inhibitors |
| 07/28/1999 | CN1224429A Androstene derivs. |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/20/1999 | US5925774 Estrenes for inducing hypothalamic effects |
| 07/20/1999 | US5925630 Neuroactive steroids of the androstane and pregnane series |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/08/1999 | WO1999033855A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS |
| 07/08/1999 | CA2316444A1 11.beta.-halogen-7.alpha.-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11.beta.-halogen-7.alpha.-substituted estratrienesas well as their use for the production of pharmaceutical agents |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 07/01/1999 | DE19758390A1 New 11beta-halo-7alpha-substituted-estratriene derivatives are useful for treatment e.g. various cancers, anovulatolial infertility, male hair loss, osteoporosis, and contraceptives |
| 06/23/1999 | EP0924219A2 Novel estrenes for inducing hypothalamic effects |
| 06/22/1999 | US5914325 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances |
| 06/09/1999 | EP0921130A2 Steroid sulphatase inhibitors |
| 05/27/1999 | WO1999025725A1 NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 11β, PREPARATION METHOD AND INTERMEDIATES, APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 05/27/1999 | CA2309242A1 Novel 19-nor steroids substituted in position 11.beta., preparation method and intermediates, application as medicines and pharmaceutical compositions containing them |
| 05/26/1999 | EP0917534A2 6,7-oxygenated steroids and uses related thereto |
| 05/14/1999 | WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life |
| 04/29/1999 | WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/14/1999 | EP0862577B1 Sulphamate derivatives of 1,3,5(10)-estratriene derivatives, methods of producing them and pharmaceutical compounds containing them |
| 04/07/1999 | EP0906332A1 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS |
| 04/06/1999 | US5892069 Estrogenic compounds as anti-mitotic agents |